Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Pathways (CLPA) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. Seuss who wrote (276)	10/25/1999 1:51:00 PM
From: tuck	Read Replies (1) \| Respond to of 566

Dr. Seuss, I try to keep my sense of humor whatever the situation. Since you keep jabbing at us, we jab back. Good clean fun, because we know none of it will change anyone's belief. As far as paying for PR, one way or the other, a company has to pay to get the word out, BW is just another method. Perhaps the medium is the message here, but I wouldn't bet much on the theory. Have you seen studies relating BW stories to poor performance? I'd like to see one, if so. I'm rather curious as to when you and Auric, etc., started shorting this puppy. If you caught it in the twenties or high teens, congratulations on a great call. However, as CLPA goes down, and the approval/disapproval is really just a guess, I wonder if you fellas aren't getting a little greedy here. I would think the risk/reward ratio is becoming less favorable to shorts these days. I suppose it's partly a matter of style. When I short I do quick hits because I work with puts, so time is working against me. Shorts who use stock can hang in there longer, but the risk is higher (in that potential loss can exceed the intial investment). Whatever, it takes shorts and longs to make the market go 'round. Good Luck, Tuck